Research ArticleArticle
The Inhibitory Potency and Selectivity of Arginine Substrate Site Nitric-Oxide Synthase Inhibitors Is Solely Determined by Their Affinity toward the Different Isoenzymes
Rainer Boer, Wolf-Rüdiger Ulrich, Thomas Klein, Berit Mirau, Sabine Haas and Ilka Baur
Molecular Pharmacology November 2000, 58 (5) 1026-1034; DOI: https://doi.org/10.1124/mol.58.5.1026
Rainer Boer
Byk Gulden Pharmaceuticals, Konstanz, Germany
Wolf-Rüdiger Ulrich
Byk Gulden Pharmaceuticals, Konstanz, Germany
Thomas Klein
Byk Gulden Pharmaceuticals, Konstanz, Germany
Berit Mirau
Byk Gulden Pharmaceuticals, Konstanz, Germany
Sabine Haas
Byk Gulden Pharmaceuticals, Konstanz, Germany
Ilka Baur
Byk Gulden Pharmaceuticals, Konstanz, Germany
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
The Inhibitory Potency and Selectivity of Arginine Substrate Site Nitric-Oxide Synthase Inhibitors Is Solely Determined by Their Affinity toward the Different Isoenzymes
Rainer Boer, Wolf-Rüdiger Ulrich, Thomas Klein, Berit Mirau, Sabine Haas and Ilka Baur
Molecular Pharmacology November 1, 2000, 58 (5) 1026-1034; DOI: https://doi.org/10.1124/mol.58.5.1026
Research ArticleArticle
The Inhibitory Potency and Selectivity of Arginine Substrate Site Nitric-Oxide Synthase Inhibitors Is Solely Determined by Their Affinity toward the Different Isoenzymes
Rainer Boer, Wolf-Rüdiger Ulrich, Thomas Klein, Berit Mirau, Sabine Haas and Ilka Baur
Molecular Pharmacology November 1, 2000, 58 (5) 1026-1034; DOI: https://doi.org/10.1124/mol.58.5.1026
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement